FDA approves Duobrii for plaque psoriasis

Adults with plaque psoriasis have a new topical to choose from. On April 25, 2019, the U.S. Food and Drug Administration approved Duobrii (halobetasol propionate and tazarotene), the first and currently only lotion indicated for adults with plaque psoriasis that contains this combination of active ingredients. This first-in-class topical is expected to be available in June. 

Manufactured by Ortho Dermatologics, Duobrii lotion combines the anti-inflammatory steroid halobetasol propionate to clear plaques with the vitamin A derivative tazarotene to help extend the clearing process by limiting the overgrowth of cells that cause plaque formation.

The prescription topical is designed to be used daily as needed (for up to 52 weeks) by rubbing a thin layer of the lotion on affected skin. A Phase 2 clinical trial found that the dual-agent treatment was superior in reducing psoriasis symptoms on the skin than treatments consisting of only halobetasol or tazarotene. 

Kelly M. Cordoro, M.D., dermatologist at the University of California, San Francisco School of Medicine, and NPF medical board member, says that such a combination topical is a first and is a convenient option for many people living with psoriasis.  

"Psoriasis impacts patients in a number of negative ways,” says Cordoro. “One of these is the time it takes to apply topical medications. Having a combination topical product available that contains two key therapeutic agents provides patients with a convenient and unique ‘two-in-one' option that offers two distinct mechanisms of action against psoriasis. This will ease the burden of applying several different medications throughout the day.” 

Since 1987, NPF has invested more than $19 million in psoriatic disease research, which has directly contributed to the wave of newly approved treatment options like Duobrii. NPF also helps connect patients with clinical trials so that more drugs may be tested and ultimately approved.

After the FDA approval process is complete, NPF provides up-to-date information on the latest treatment options to health care providers and offers resources to ensure patients access the best care possible

Get the latest treatment info
To learn more about your treatment options, including information on Duobrii lotion, contact the Patient Navigation Center. NPF patient navigators offer free resources and personalized support to help you live your healthiest life with psoriatic disease.


Driving discovery, creating community

For more than 50 years, we’ve been driving efforts to cure psoriatic disease and improve the lives of those affected. But there’s still plenty to do! Learn how you can help our advocacy team shape the laws and policies that affect people with psoriasis and psoriatic arthritis – in your state and across the country. Help us raise funds to support research by joining Team NPF, where you can walk, run, cycle, play bingo or create your own fundraising event. If you or someone you love needs free, personalized support for living a healthier life with psoriatic disease, contact our Patient Navigation Center. And keep the National Psoriasis Foundation going strong by making a donation today. Together, we will find a cure.

Recent Advance Posts

Tami Seretti is one of three individuals who have distinguished themselves with...
The 2019 NPF annual survey is your opportunity to share your data and help...
Facebook fundraiser
It’s easy to start supporting NPF research with your own personal fundraising...
Data collection alone won't find us a cure for psoriatic disease. First we...
The best treatment starts with a team of medical professionals who are up-to-...
NPF board of directors member Richard Seiden shares his notes.
Kory Schrom, M.D.
Researcher Kory Schrom’s interest in the microbiome may answer this and other...
How one couple battles the indignities of psoriatic disease, from supporting...
NPF meets with other national health care organizations about access to care...